ESCONDIDO, Calif., May 11, 2020 /PRNewswire/ -- TearLab Corporation (OTCQB: TEAR), a leader in Ocular Surface Diagnostics, today announced it has entered into a definitive agreement pursuant to which ...
A search of the Medicines and Healthcare Products Regulatory Agency website revealed no manufacturer Field Safety Notices or Medical Device Alerts for this device. No reports of adverse events were ...
SAN DIEGO, May 17, 2011 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced today a unique new Individuelle Gesundheitsleistungen ("individual health ...
ESCONDIDO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- In light of recent market rumors, TearLab Corporation (TEAR) (“TearLab”) today confirmed that TearLab is engaged in advanced discussions regarding a ...
Table 1: Overview of the Caffery et al. (2014) study Table 2: Overview of the Jacobi et al. (2011) study Table 3: Overview of the Messmer et al. (2010) study Table 4: Overview of the Lemp et al. (2011 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback